Table of Content

1 Therapeutic Vaccines Market Overview
1.1 Therapeutic Vaccines Product Scope
1.2 Therapeutic Vaccines Segment by Type
1.2.1 Global Therapeutic Vaccines Sales by Type (2016 & 2021 & 2027)
1.2.2 Peptide Therapeutic Vaccine
1.2.3 Cell Therapeutic Vaccine
1.2.4 Nucleic Acid Therapeutic Vaccine
1.3 Therapeutic Vaccines Segment by Application
1.3.1 Global Therapeutic Vaccines Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Oncotherapy
1.3.3 Hepatitis B
1.3.4 Tuberculosis
1.3.5 Herpes Simplex Virus
1.3.6 Others
1.4 Therapeutic Vaccines Market Estimates and Forecasts (2016-2027)
1.4.1 Global Therapeutic Vaccines Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Therapeutic Vaccines Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Therapeutic Vaccines Price Trends (2016-2027)

2 Therapeutic Vaccines Estimates and Forecasts by Region
2.1 Global Therapeutic Vaccines Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Therapeutic Vaccines Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Therapeutic Vaccines Sales Market Share by Region (2016-2021)
2.2.2 Global Therapeutic Vaccines Revenue Market Share by Region (2016-2021)
2.3 Global Therapeutic Vaccines Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Therapeutic Vaccines Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Therapeutic Vaccines Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Therapeutic Vaccines Estimates and Projections (2016-2027)
2.4.2 Europe Therapeutic Vaccines Estimates and Projections (2016-2027)
2.4.3 China Therapeutic Vaccines Estimates and Projections (2016-2027)
2.4.4 Japan Therapeutic Vaccines Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Therapeutic Vaccines Estimates and Projections (2016-2027)
2.4.6 India Therapeutic Vaccines Estimates and Projections (2016-2027)

3 Global Therapeutic Vaccines Competition Landscape by Players
3.1 Global Top Therapeutic Vaccines Players by Sales (2016-2021)
3.2 Global Top Therapeutic Vaccines Players by Revenue (2016-2021)
3.3 Global Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Therapeutic Vaccines as of 2020)
3.4 Global Therapeutic Vaccines Average Price by Company (2016-2021)
3.5 Manufacturers Therapeutic Vaccines Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Therapeutic Vaccines Market Size by Type
4.1 Global Therapeutic Vaccines Historic Market Review by Type (2016-2021)
4.1.1 Global Therapeutic Vaccines Sales Market Share by Type (2016-2021)
4.1.2 Global Therapeutic Vaccines Revenue Market Share by Type (2016-2021)
4.1.3 Global Therapeutic Vaccines Price by Type (2016-2021)
4.2 Global Therapeutic Vaccines Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Therapeutic Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Therapeutic Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Global Therapeutic Vaccines Price Forecast by Type (2022-2027)

5 Global Therapeutic Vaccines Market Size by Application
5.1 Global Therapeutic Vaccines Historic Market Review by Application (2016-2021)
5.1.1 Global Therapeutic Vaccines Sales Market Share by Application (2016-2021)
5.1.2 Global Therapeutic Vaccines Revenue Market Share by Application (2016-2021)
5.1.3 Global Therapeutic Vaccines Price by Application (2016-2021)
5.2 Global Therapeutic Vaccines Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Therapeutic Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Therapeutic Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Therapeutic Vaccines Price Forecast by Application (2022-2027)

6 North America Therapeutic Vaccines Market Facts & Figures
6.1 North America Therapeutic Vaccines Sales by Company
6.1.1 North America Therapeutic Vaccines Sales by Company (2016-2021)
6.1.2 North America Therapeutic Vaccines Revenue by Company (2016-2021)
6.2 North America Therapeutic Vaccines Sales Breakdown by Type
6.2.1 North America Therapeutic Vaccines Sales Breakdown by Type (2016-2021)
6.2.2 North America Therapeutic Vaccines Sales Breakdown by Type (2022-2027)
6.3 North America Therapeutic Vaccines Sales Breakdown by Application
6.3.1 North America Therapeutic Vaccines Sales Breakdown by Application (2016-2021)
6.3.2 North America Therapeutic Vaccines Sales Breakdown by Application (2022-2027)

7 Europe Therapeutic Vaccines Market Facts & Figures
7.1 Europe Therapeutic Vaccines Sales by Company
7.1.1 Europe Therapeutic Vaccines Sales by Company (2016-2021)
7.1.2 Europe Therapeutic Vaccines Revenue by Company (2016-2021)
7.2 Europe Therapeutic Vaccines Sales Breakdown by Type
7.2.1 Europe Therapeutic Vaccines Sales Breakdown by Type (2016-2021)
7.2.2 Europe Therapeutic Vaccines Sales Breakdown by Type (2022-2027)
7.3 Europe Therapeutic Vaccines Sales Breakdown by Application
7.3.1 Europe 123 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 123 Sales Breakdown by Application (2022-2027)

8 China Therapeutic Vaccines Market Facts & Figures
8.1 China Therapeutic Vaccines Sales by Company
8.1.1 China Therapeutic Vaccines Sales by Company (2016-2021)
8.1.2 China Therapeutic Vaccines Revenue by Company (2016-2021)
8.2 China Therapeutic Vaccines Sales Breakdown by Type
8.2.1 China Therapeutic Vaccines Sales Breakdown by Type (2016-2021)
8.2.2 China Therapeutic Vaccines Sales Breakdown by Type (2022-2027)
8.3 China Therapeutic Vaccines Sales Breakdown by Application
8.3.1 China 144 Sales Breakdown by Application (2016-2021)
8.3.2 China 144 Sales Breakdown by Application (2022-2027)

9 Japan Therapeutic Vaccines Market Facts & Figures
9.1 Japan Therapeutic Vaccines Sales by Company
9.1.1 Japan Therapeutic Vaccines Sales by Company (2016-2021)
9.1.2 Japan Therapeutic Vaccines Revenue by Company (2016-2021)
9.2 Japan Therapeutic Vaccines Sales Breakdown by Type
9.2.1 Japan Therapeutic Vaccines Sales Breakdown by Type (2016-2021)
9.2.2 Japan Therapeutic Vaccines Sales Breakdown by Type (2022-2027)
9.3 Japan Therapeutic Vaccines Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Therapeutic Vaccines Market Facts & Figures
10.1 Southeast Asia Therapeutic Vaccines Sales by Company
10.1.1 Southeast Asia Therapeutic Vaccines Sales by Company (2016-2021)
10.1.2 Southeast Asia Therapeutic Vaccines Revenue by Company (2016-2021)
10.2 Southeast Asia Therapeutic Vaccines Sales Breakdown by Type
10.2.1 Southeast Asia Therapeutic Vaccines Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Therapeutic Vaccines Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Therapeutic Vaccines Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Therapeutic Vaccines Market Facts & Figures
11.1 India Therapeutic Vaccines Sales by Company
11.1.1 India Therapeutic Vaccines Sales by Company (2016-2021)
11.1.2 India Therapeutic Vaccines Revenue by Company (2016-2021)
11.2 India Therapeutic Vaccines Sales Breakdown by Type
11.2.1 India Therapeutic Vaccines Sales Breakdown by Type (2016-2021)
11.2.2 India Therapeutic Vaccines Sales Breakdown by Type (2022-2027)
11.3 India Therapeutic Vaccines Sales Breakdown by Application
11.3.1 India Therapeutic Vaccines Sales Breakdown by Application (2016-2021)
11.3.2 India Therapeutic Vaccines Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Therapeutic Vaccines Business
12.1 Northeast Biotherapeutics
12.1.1 Northeast Biotherapeutics Corporation Information
12.1.2 Northeast Biotherapeutics Business Overview
12.1.3 Northeast Biotherapeutics Therapeutic Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Northeast Biotherapeutics Therapeutic Vaccines Products Offered
12.1.5 Northeast Biotherapeutics Recent Development
12.2 Agenus
12.2.1 Agenus Corporation Information
12.2.2 Agenus Business Overview
12.2.3 Agenus Therapeutic Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Agenus Therapeutic Vaccines Products Offered
12.2.5 Agenus Recent Development
12.3 Vaccinogen Inc
12.3.1 Vaccinogen Inc Corporation Information
12.3.2 Vaccinogen Inc Business Overview
12.3.3 Vaccinogen Inc Therapeutic Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Vaccinogen Inc Therapeutic Vaccines Products Offered
12.3.5 Vaccinogen Inc Recent Development
12.4 CIMAB S.A
12.4.1 CIMAB S.A Corporation Information
12.4.2 CIMAB S.A Business Overview
12.4.3 CIMAB S.A Therapeutic Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 CIMAB S.A Therapeutic Vaccines Products Offered
12.4.5 CIMAB S.A Recent Development
12.5 Dendreon
12.5.1 Dendreon Corporation Information
12.5.2 Dendreon Business Overview
12.5.3 Dendreon Therapeutic Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Dendreon Therapeutic Vaccines Products Offered
12.5.5 Dendreon Recent Development
12.6 Corixa
12.6.1 Corixa Corporation Information
12.6.2 Corixa Business Overview
12.6.3 Corixa Therapeutic Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Corixa Therapeutic Vaccines Products Offered
12.6.5 Corixa Recent Development
12.7 AVAX Technologies
12.7.1 AVAX Technologies Corporation Information
12.7.2 AVAX Technologies Business Overview
12.7.3 AVAX Technologies Therapeutic Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 AVAX Technologies Therapeutic Vaccines Products Offered
12.7.5 AVAX Technologies Recent Development
...

13 Therapeutic Vaccines Manufacturing Cost Analysis
13.1 Therapeutic Vaccines Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Therapeutic Vaccines
13.4 Therapeutic Vaccines Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Therapeutic Vaccines Distributors List
14.3 Therapeutic Vaccines Customers

15 Market Dynamics
15.1 Therapeutic Vaccines Market Trends
15.2 Therapeutic Vaccines Drivers
15.3 Therapeutic Vaccines Market Challenges
15.4 Therapeutic Vaccines Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Therapeutic Vaccines Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Therapeutic Vaccines Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Therapeutic Vaccines Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Therapeutic Vaccines Sales (K Units) by Region (2016-2021)
Table 5. Global Therapeutic Vaccines Sales Market Share by Region (2016-2021)
Table 6. Global Therapeutic Vaccines Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Therapeutic Vaccines Revenue Share by Region (2016-2021)
Table 8. Global Therapeutic Vaccines Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Therapeutic Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Therapeutic Vaccines Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Therapeutic Vaccines Revenue Share Forecast by Region (2022-2027)
Table 12. Global Therapeutic Vaccines Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Therapeutic Vaccines Sales Share by Company (2016-2021)
Table 14. Global Therapeutic Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Therapeutic Vaccines Revenue Share by Company (2016-2021)
Table 16. Global Therapeutic Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Vaccines as of 2020)
Table 17. Global Therapeutic Vaccines Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Therapeutic Vaccines Manufacturing Sites and Area Served
Table 19. Manufacturers Therapeutic Vaccines Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Therapeutic Vaccines Sales (K Units) by Type (2016-2021)
Table 22. Global Therapeutic Vaccines Sales Share by Type (2016-2021)
Table 23. Global Therapeutic Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Therapeutic Vaccines Price (USD/Unit) by Type (2016-2021)
Table 25. Global Therapeutic Vaccines Sales Share by Type (2022-2027)
Table 26. Global Therapeutic Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Therapeutic Vaccines Revenue Share by Type (2022-2027)
Table 28. Global Therapeutic Vaccines Price (USD/Unit) by Type (2022-2027)
Table 29. Global Therapeutic Vaccines Sales (K Units) by Application (2016-2021)
Table 30. Global Therapeutic Vaccines Sales Share by Application (2016-2021)
Table 31. Global Therapeutic Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Therapeutic Vaccines Price (USD/Unit) by Application (2016-2021)
Table 33. Global Therapeutic Vaccines Sales (K Units) by Application (2022-2027)
Table 34. Global Therapeutic Vaccines Sales Share by Application (2022-2027)
Table 35. Global Therapeutic Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Therapeutic Vaccines Revenue Share by Application (2022-2027)
Table 37. Global Therapeutic Vaccines Price (USD/Unit) by Application (2022-2027)
Table 38. North America Therapeutic Vaccines Sales (K Units) by Company (2016-2021)
Table 39. North America Therapeutic Vaccines Sales Market Share by Company (2016-2021)
Table 40. North America Therapeutic Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Therapeutic Vaccines Revenue Market Share by Company (2016-2021)
Table 42. North America Therapeutic Vaccines Sales by Type (2016-2021) & (K Units)
Table 43. North America Therapeutic Vaccines Sales Market Share by Type (2016-2021)
Table 44. North America Therapeutic Vaccines Sales by Type (2022-2027) & (K Units)
Table 45. North America Therapeutic Vaccines Sales Market Share by Type (2022-2027)
Table 46. North America Therapeutic Vaccines Sales by Application (2016-2021) & (K Units)
Table 47. North America Therapeutic Vaccines Sales Market Share by Application (2016-2021)
Table 48. North America Therapeutic Vaccines Sales by Application (2022-2027) & (K Units)
Table 49. North America Therapeutic Vaccines Sales Market Share by Application (2022-2027)
Table 50. Europe Therapeutic Vaccines Sales (K Units) by Company (2016-2021)
Table 51. Europe Therapeutic Vaccines Sales Market Share by Company (2016-2021)
Table 52. Europe Therapeutic Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Therapeutic Vaccines Revenue Market Share by Company (2016-2021)
Table 54. Europe Therapeutic Vaccines Sales by Type (2016-2021) & (K Units)
Table 55. Europe Therapeutic Vaccines Sales Market Share by Type (2016-2021)
Table 56. Europe Therapeutic Vaccines Sales by Type (2022-2027) & (K Units)
Table 57. Europe Therapeutic Vaccines Sales Market Share by Type (2022-2027)
Table 58. Europe Therapeutic Vaccines Sales by Application (2016-2021) & (K Units)
Table 59. Europe Therapeutic Vaccines Sales Market Share by Application (2016-2021)
Table 60. Europe Therapeutic Vaccines Sales by Application (2022-2027) & (K Units)
Table 61. Europe Therapeutic Vaccines Sales Market Share by Application (2022-2027)
Table 62. China Therapeutic Vaccines Sales (K Units) by Company (2016-2021)
Table 63. China Therapeutic Vaccines Sales Market Share by Company (2016-2021)
Table 64. China Therapeutic Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Therapeutic Vaccines Revenue Market Share by Company (2016-2021)
Table 66. China Therapeutic Vaccines Sales by Type (2016-2021) & (K Units)
Table 67. China Therapeutic Vaccines Sales Market Share by Type (2016-2021)
Table 68. China Therapeutic Vaccines Sales by Type (2022-2027) & (K Units)
Table 69. China Therapeutic Vaccines Sales Market Share by Type (2022-2027)
Table 70. China Therapeutic Vaccines Sales by Application (2016-2021) & (K Units)
Table 71. China Therapeutic Vaccines Sales Market Share by Application (2016-2021)
Table 72. China Therapeutic Vaccines Sales by Application (2022-2027) & (K Units)
Table 73. China Therapeutic Vaccines Sales Market Share by Application (2022-2027)
Table 74. Japan Therapeutic Vaccines Sales (K Units) by Company (2016-2021)
Table 75. Japan Therapeutic Vaccines Sales Market Share by Company (2016-2021)
Table 76. Japan Therapeutic Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Therapeutic Vaccines Revenue Market Share by Company (2016-2021)
Table 78. Japan Therapeutic Vaccines Sales by Type (2016-2021) & (K Units)
Table 79. Japan Therapeutic Vaccines Sales Market Share by Type (2016-2021)
Table 80. Japan Therapeutic Vaccines Sales by Type (2022-2027) & (K Units)
Table 81. Japan Therapeutic Vaccines Sales Market Share by Type (2022-2027)
Table 82. Japan Therapeutic Vaccines Sales by Application (2016-2021) & (K Units)
Table 83. Japan Therapeutic Vaccines Sales Market Share by Application (2016-2021)
Table 84. Japan Therapeutic Vaccines Sales by Application (2022-2027) & (K Units)
Table 85. Japan Therapeutic Vaccines Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Therapeutic Vaccines Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Therapeutic Vaccines Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Therapeutic Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Therapeutic Vaccines Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Therapeutic Vaccines Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Therapeutic Vaccines Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Therapeutic Vaccines Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Therapeutic Vaccines Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Therapeutic Vaccines Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Therapeutic Vaccines Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Therapeutic Vaccines Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Therapeutic Vaccines Sales Market Share by Application (2022-2027)
Table 98. India Therapeutic Vaccines Sales (K Units) by Company (2016-2021)
Table 99. India Therapeutic Vaccines Sales Market Share by Company (2016-2021)
Table 100. India Therapeutic Vaccines Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Therapeutic Vaccines Revenue Market Share by Company (2016-2021)
Table 102. India Therapeutic Vaccines Sales by Type (2016-2021) & (K Units)
Table 103. India Therapeutic Vaccines Sales Market Share by Type (2016-2021)
Table 104. India Therapeutic Vaccines Sales by Type (2022-2027) & (K Units)
Table 105. India Therapeutic Vaccines Sales Market Share by Type (2022-2027)
Table 106. India Therapeutic Vaccines Sales by Application (2016-2021) & (K Units)
Table 107. India Therapeutic Vaccines Sales Market Share by Application (2016-2021)
Table 108. India Therapeutic Vaccines Sales by Application (2022-2027) & (K Units)
Table 109. India Therapeutic Vaccines Sales Market Share by Application (2022-2027)
Table 110. Northeast Biotherapeutics Corporation Information
Table 111. Northeast Biotherapeutics Description and Business Overview
Table 112. Northeast Biotherapeutics Therapeutic Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Northeast Biotherapeutics Therapeutic Vaccines Product
Table 114. Northeast Biotherapeutics Recent Development
Table 115. Agenus Corporation Information
Table 116. Agenus Description and Business Overview
Table 117. Agenus Therapeutic Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Agenus Therapeutic Vaccines Product
Table 119. Agenus Recent Development
Table 120. Vaccinogen Inc Corporation Information
Table 121. Vaccinogen Inc Description and Business Overview
Table 122. Vaccinogen Inc Therapeutic Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Vaccinogen Inc Therapeutic Vaccines Product
Table 124. Vaccinogen Inc Recent Development
Table 125. CIMAB S.A Corporation Information
Table 126. CIMAB S.A Description and Business Overview
Table 127. CIMAB S.A Therapeutic Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. CIMAB S.A Therapeutic Vaccines Product
Table 129. CIMAB S.A Recent Development
Table 130. Dendreon Corporation Information
Table 131. Dendreon Description and Business Overview
Table 132. Dendreon Therapeutic Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Dendreon Therapeutic Vaccines Product
Table 134. Dendreon Recent Development
Table 135. Corixa Corporation Information
Table 136. Corixa Description and Business Overview
Table 137. Corixa Therapeutic Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Corixa Therapeutic Vaccines Product
Table 139. Corixa Recent Development
Table 140. AVAX Technologies Corporation Information
Table 141. AVAX Technologies Description and Business Overview
Table 142. AVAX Technologies Therapeutic Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. AVAX Technologies Therapeutic Vaccines Product
Table 144. AVAX Technologies Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Therapeutic Vaccines Distributors List
Table 148. Therapeutic Vaccines Customers List
Table 149. Therapeutic Vaccines Market Trends
Table 150. Therapeutic Vaccines Market Drivers
Table 151. Therapeutic Vaccines Market Challenges
Table 152. Therapeutic Vaccines Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Therapeutic Vaccines Product Picture
Figure 2. Global Therapeutic Vaccines Sales Market Share by Type in 2021 & 2027
Figure 3. Peptide Therapeutic Vaccine Product Picture
Figure 4. Cell Therapeutic Vaccine Product Picture
Figure 5. Nucleic Acid Therapeutic Vaccine Product Picture
Figure 6. Global Therapeutic Vaccines Sales Market Share by Application in 2021 & 2027
Figure 7. Oncotherapy Examples
Figure 8. Hepatitis B Examples
Figure 9. Tuberculosis Examples
Figure 10. Herpes Simplex Virus Examples
Figure 11. Others Examples
Figure 12. Global Therapeutic Vaccines Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Therapeutic Vaccines Sales Growth Rate (2016-2027) & (US$ Million)
Figure 14. Global Therapeutic Vaccines Sales (K Units) Growth Rate (2016-2027)
Figure 15. Global Therapeutic Vaccines Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 16. Global Therapeutic Vaccines Revenue Market Share by Region: 2016 VS 2021
Figure 17. Global Therapeutic Vaccines Revenue Market Share by Region: 2021 VS 2027
Figure 18. North America Therapeutic Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. North America Therapeutic Vaccines Sales (K Units) Growth Rate (2016-2027)
Figure 20. Europe Therapeutic Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Europe Therapeutic Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 22. China Therapeutic Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. China Therapeutic Vaccines Sales (Million USD) and Growth Rate (2016-2027)
Figure 24. Japan Therapeutic Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Japan Therapeutic Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Southeast Asia Therapeutic Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. Southeast Asia Therapeutic Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 28. India Therapeutic Vaccines Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. India Therapeutic Vaccines Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Global 5 Largest Therapeutic Vaccines Players Market Share by Revenue in Therapeutic Vaccines: 2016 & 2020
Figure 31. Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 32. Global Therapeutic Vaccines Revenue Share by Type (2016-2021)
Figure 33. Global Therapeutic Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 34. Global Therapeutic Vaccines Revenue Share by Application (2016-2021)
Figure 35. Global Therapeutic Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Therapeutic Vaccines Sales Market Share by Type in 2020
Figure 37. North America Therapeutic Vaccines Sales Market Share by Application in 2020
Figure 38. Europe Therapeutic Vaccines Sales Market Share by Type in 2020
Figure 39. Europe Therapeutic Vaccines Sales Market Share by Application in 2020
Figure 40. China Therapeutic Vaccines Sales Market Share by Type in 2020
Figure 41. China Therapeutic Vaccines Sales Market Share by Application in 2020
Figure 42. Japan Therapeutic Vaccines Sales Market Share by Type in 2020
Figure 43. Japan Therapeutic Vaccines Sales Market Share by Application in 2020
Figure 44. Southeast Asia Therapeutic Vaccines Sales Market Share by Type in 2020
Figure 45. Southeast Asia Therapeutic Vaccines Sales Market Share by Application in 2020
Figure 46. India Therapeutic Vaccines Sales Market Share by Type in 2020
Figure 47. India Therapeutic Vaccines Sales Market Share by Application in 2020
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Therapeutic Vaccines
Figure 50. Manufacturing Process Analysis of Therapeutic Vaccines
Figure 51. Therapeutic Vaccines Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed